Skip to main content

Advertisement

Table 3 STR profiling of PDX tumor samples

From: Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

PDX TH01 D21S11 D5S818 D13S317 D7S820 D16S539 CSF1PO AMEL vWA TPOX
TKO-001_P1 7 7 29 29 7 7 11 11 10 11 11 12 12 12 X Y 18 18 11 11
TKO-001_P2 7 7 29 29 7 7 11 11 10 11 11 12 12 12 X Y 18 18 11 11
TKO-002_P1 7 9.3 27 31 13 13 11 12 8 11 9 12 11 11 X X 16 17 9 9
TKO-002_P2 7 9.3 27 31 13 13 11 12 8 11 9 12 11 11 X X 16 17 9 9
TKO-003_P1 7 7 29 29 11 12 11 11 10 10 9 9 7 13 X X 16 16 9 11
TKO-003_P2 7 7 29 29 11 12 11 11 10 10 9 9 7 13 X X 16 16 9 11
TKO-005_P1 8 9.3 29 31 12 12 12 12 10 10 8 9 10 12 X X 19 19 8 9
TKO-005_P2 8 9.3 29 31 12 12 12 12 10 10 8 9 10 12 X X 19 19 8 9
TKO-008_P2 6 6 30 31 13 13 10 10 11 12 9 9 12 12 X X 17 18 8 8
TKO-008_P1 6 6 30 31 13 13 10 10 11 12 9 9 12 12 X X 17 18 8 8